Key result
Congenital heart disease is linked to worse intent-to-treat survival in pediatric heart transplant candidates.
Why the study?
Separate waitlist and post-transplant mortality metrics provide an incomplete picture in pediatric heart transplantation, and intent-to-treat analyses evaluating the impact of transplant indication following the 2016 allocation policy are less prevalent in the literature.
Does having congenital heart disease as a transplant indication impact intent-to-treat mortality in pediatric patients listed for heart transplantation?
Cohort
Yes
Does having congenital heart disease as a transplant indication impact intent-to-treat mortality in pediatric patients listed for heart transplantation?
Pediatric heart transplant candidates with congenital heart disease experience inferior intent-to-treat survival despite the 2016 allocation policy prioritization, and a novel predictive score (c-statistic = 0.74) can help risk-stratify these patients.
Answers are grounded in this paper and cite their sources.
Supports enhanced monitoring of high-risk pediatric CHD transplant candidates; leaves open whether policy refinements improve equity.
While the impact of patient characteristics on waitlist and post-transplant mortality in pediatric heart transplantation has been widely studied, these metrics are limited in their ability to provide a complete picture for patients and their families. In contrast, less prevalent in the literature is an intent-to-treat analysis approach, which provides a single data point that encompasses both of these measures. This retrospective study examines pediatric patients listed for heart transplantation in the United Network for Organ Sharing (UNOS) database between 2016 and 2025, evaluating the impact of transplant indication on intent-to-treat outcomes following the implementation of the 2016 allocation policy, which prioritizes children with congenital heart disease (CHD) on inotropic support. Kaplan-Meier analysis by transplant indication was performed across all pediatric patients listed during the study period, followed by Cox regression analyses using clinical and demographic covariates. In this initial analysis, CHD patients had poorer intent-to-treat outcomes. Risk and protective factors in this particularly high-risk population were then identified using univariable Cox regression. Significant factors ( p < 0.05) were entered into a multivariable Cox regression, which was used to generate a predictive score for one-year intent-to-treat mortality (c-statistic = 0.74). Risk factors significant in the multivariable analysis were age 0–1 years, geographic region, public (rather than private) insurance, need for life support and/or hemodialysis, and low serum albumin level. Following external validation and study of transplant timing on outcomes, these findings may serve as an additional tool to identify and prioritize high-risk patients and target modifiable risk factors.
No takes yet. Share an insight, caveat, or question.
Gomes-Jourdan et al. (2026) conducted a cohort in Pediatric patients listed for heart transplantation. Congenital heart disease (CHD) as transplant indication vs. Other transplant indications was evaluated on Intent-to-treat mortality. Congenital heart disease patients listed for pediatric heart transplantation had poorer intent-to-treat outcomes, with a multivariable risk score predicting 1-year mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: